comprehensive -WSS

comprehensive

author：explore 2025-09-03 03:37:33 - browse：1

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Structure Therapeutics oral GLP

WSS

Medicare’s new pay boost for primary care is angering specialists

Senators tussle over abortion against the backdrop of a presidential campaign

STAT wants to know your pick for a great summer read or listen

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Ventyx halts psoriasis drug development after lackluster trial results

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Wikipedia

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

New air purifier tech could be key to improving indoor air quality

STAT wants to know your pick for a great summer read or listen

Activists slam private health insurers over coverage restrictions

FTC loses bid to block Novant's North Carolina hospital merger

Anesthesiologist group: stop taking Ozempic before surgery

Sutter Health’s antitrust win overturned by appeals court

Medical leaders decry Supreme Court decision on affirmative action

Stopping antidepressants leads to symptoms for 1 in 6 patients

The cancer drug shortage isn’t new — and neither are the solutions

First transplant of an entire human eye performed

entertainment

Senators tussle over abortion against the backdrop of a presidential campaign

Publishing genetic code of viruses could cause disaster

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Fight over Supreme Court dialysis ruling puts kidney patients at risk

CMS got Medicare Advantage quality rating wrong, judge rules

Eli Lilly’s Zepbound improved liver scarring in mid

hotspot

Wikipedia

hotspot

hotspot